Chimeric antigen receptor (CAR) t-cell therapy – The Bloodline with LLS
Chimeric antigen receptor (CAR) t-cell therapy - The Bloodline with LLS
Podcast Description
A Podcast for Patients and Caregivers
Podcast Insights
Content Themes
Explores topics related to cancer treatment innovations, patient experiences, healthcare disparities, and caregiver roles, with specific episodes discussing CAR T-cell therapy, chronic lymphocytic leukemia advancements, and the importance of equitable access to cancer care.
A Podcast for Patients and Caregivers
Non-Hodgkin lymphoma (NHL) can sound overwhelming, but what does it really mean for patients and families? In this episode, we speak to Dr. Jean Koff of Winship Cancer Institute of Emory University, who breaks down the big picture of NHL: what it is, how it’s an umbrella term for multiple subtypes, and what today’s treatments and tomorrow’s innovations could mean for you. From understanding subtypes and staging to exploring options like watchful waiting, chemotherapy, and cutting-edge immunotherapies, we cover what matters most: knowledge, clarity, and hope.
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
- Non-Hodgkin lymphoma
- The Lymphoma Guide
- Lugano staging system
- Immunotherapy fact sheet
- CAR T-cell therapy
- Allogeneic stem cell transplantation
- Clinical Trial Support Center
- Online NHL Chat
Additional Blood Cancer United Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Support groups
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Advocacy and Public Policy
- Patient Community
- Mental Health Resources
Supported by AbbVie Inc. and Genentech, A Member of the Roche Group.
The post The Big Picture on Non-Hodgkin Lymphoma: Treatments, Trends, and Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.